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A B S T R A C T
Darier's disease (Dyskeratosis follicularis, DD) is a genetic disorder characterized by
pathogenetic changes of keratinization with variant forms of cutaneous phenotype. Re-
cently, it has been showed that Darier's disease cause mutations in the ATP2A2 gene, at
12q24.1. The gene encodes sarco-endoplasmic reticulum calcium ATPase type 2 (SERCA2).
Mutations in exon 15 are reported to be the most consistent mutations associated with
the acral hemorrhagic type of Darier's disease. By direct sequencing we investigated
exon 15 of the ATP2A2 gene in a Croatian family in which one member had a hemor-
rhagic Darier's disease, but did not record any mutation in the family we investigated.
Our results show that mutations in exon 15 of the ATP2A2 gene are not a necessary pre-
requisite for acral hemorrhagic type of Darier's disease. Our finding support the vari-
ability of clinical manifestations of Darier's disease and lack of genotype/phenotype
consistency.
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Introduction
Dyskeratosis follicularis (Darier's Dis-
ease, DD, MIM#124200) is a genetic skin
disorder characterized by the loss of ad-
hesion between epidermal cells (acantho-
lysis) and abnormal keratinization1. Its
prevalence has been estimated at 1.8/
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100,000 inhabitants from Central Eng-
land, 2.8/100,000 from Northeast Eng-
land, 1/100,000 from Denmark, 2.2/
100,000 from Slovenia and 1.3/100,000
from our country Croatia2.
Dyskeratosis follicularis is caused by
mutation in the ATP2A2 gene at 12q23-
q24.13,4. This gene (GenBank accession
nos M23115 and M23114) encodes the
sarco/endoplasmic reticulum calcium-
pumping ATPase (SERCA2), which is
highly expressed in keratinocytes. The
magnesium dependent enzyme catalyzes
the hydrolysis of ATP coupled with the
transport of the calcium5. It transports
calcium ions from the cytosol into the
sarcoplasmic/endoplasmic reticulum and
has a central role in intracellular calcium
signaling4.
The gene encodes for two isoforms
generated by alternative splicing: class
1/ATP2A2a and class 2/ATP2A2b that
differ in their carboxy termini and have
distinct tissue-expression patterns6. The
first is located primarily in heart and
slow-twitch skeletal muscle, whereas
SERCA2b is present in smooth muscle
and nonmuscle tissues. In adult skin sec-
tions only the longer isoform, SERCA2b
is detected7. Extended mutation analysis
in European Darier's disease patients us-
ing SSCP and/or direct sequencing identi-
fied 40 different patient specific muta-
tions in 47 families4,8. The majority (23 of
40) was likely to result in nonsense-medi-
ated RNA decay. The remaining 17 were
missense mutations distributed through-
out the protein and were associated sig-
nificantly with atypical clinical features.
The clearest association was with the fa-
milial hemorrhagic variant, where all 4
families tested had a missense mutation.
Three of the families (1 Scottish and 2 un-
related Italian families) exhibited the
same asn767-to-ser substitution in the
M5 transmembrane domain and a fourth
family, from Sweden, had a cys268-to-phe
substitution in the M3 transmembrane
domain7,9 (Figure 1). Additional muta-
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Fig. 1. Location of mutations in the human ATP2A2 polypeptide associated with hemorrhagic vari-
ant of Darier's disease (encoded in exon 15). The predicted secondary structure includes three cyto-
plasmic domains separated by a stalk sector from the transmembrane part of the molecule. The cy-
toplasmic domains contain a beta-strand, a phosporilation domain and an ATP-binding domain.
ATP binding domain is linked to the transmembrane region which includes 10 transmembrane
coiled-coil helices, of which four contain Ca2+ binding sites. The mutations are represented by cir-
cles (missense), a triangle (deletion) and a square (frameshift and nonsense).
tions were found in two Chinese fami-
lies10, but were not associated with spe-
cific clinical feature.
Clinically, dyskeratosis follicularis, ma-
nifests with keratotic papules and histo-
logically by dyskeratosis11. The disease
begins very slowly, usually between 8 and
15 years of age, as numerous follicular
papules covered with gray-brown crusts12.
Confluent papules enlarge and develop
into verrucous or vegetating plaques. The
papules are located on the seborrheic ar-
eas, flexural surfaces and sun- exposed
areas of the skin. Nail changes are also
an important sign13. The penetrance of
the disease is complete in adults although
expressivity is variable. Neuropsychiatric
features, including mental retardation
(in 10% of patients), schizophrenia, bipo-
lar disorder, and epilepsy, have also been
reported8. Stress, UV exposure, heat, sweat,
friction and oral contraceptives may exac-
erbate disease symptoms1.
Electron microscopy reveals that the
essential abnormality is a defect in the
synthesis and organization of the tono-
filament-desmosome complex (attach-
ment plaque), as well as perinuclear ag-
gregation of keratin filaments and cyto-
plasmic vacuolization4.
It has been shown that the most con-
sistent familial variant of Darier's dis-
ease, the one with acral hemorrhagic le-
sions7, is associated with mutations in
exon 15 of the ATP2A2 gene. For this rea-
son we decided to investigate exon 15 of
the ATP2A2 gene in a Croatian family in
which one member had a severe case of
Darier's disease. We were curious to in-
vestigate genetic background of this ex-
tremely severe case of DD and discover
whether mutations in exon 15 are prereq-




The diagnosis was made by dermatol-
ogists based on clinical and histopatho-
logical findings. History and clinical find-
ings were recorded in 4 family members
including neuropsychiatric and cardiac
disease. The following clinical parame-
ters were assessed: age of onset, pattern
of disease, exacerbating factors, respon-
siveness to treatment, susceptibility to
infection and progression of the disease
with age. The disease was classified as
severe.
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Fig. 2. Acral hemorrhagic type of Darier's disease. Patient with dyskeratosis follicularis before
treatment. A. Crusting papules, simulating seborrhea, on the seborrheic areas of the face, forehead,
ears and nasolabial furrows and on the scalp. B. Warty follicular papules widely distributed over
the chest, on the seborrheic areas of the trunk. There are skin-colored, greasy, crusted papules, yel-
low-brown or brown. C. Punctate keratoses, haemorrhagic macules, papillomatous masses, vege-
tating, hypertrophic and warty masses with pyogenic infections on the lower extremities.
DNA extraction
We collected peripheral blood samples
from 4 members of a Croatian family in
which a proband had severe case of Da-
rier's disease. We also obtained skin bi-
opsy from the proband. Our study was
approved by the local Ethics committee
and all the family members gave infor-
med consent. Genomic DNA was extrac-
ted from peripheral blood leukocytes us-
ing standard methods. Blood samples (5
ml) were lysed with 7 ml distilled water
and centrifuged (15 min/5000 g). The pel-
let was than processed for DNA extrac-
tion using 1 ml extraction buffer (10 mM
Tris HCl, pH 8.0; 0.1 M EDTA, pH 8.0;
0.5% sodium dodecyl sulfate) and incu-
bated with proteinase K (final concentra-
tion 100 g/ml; Sigma, USA; overnight at
37 °C). Phenol chloroform extraction and
ethanol precipitation followed.
Polymerase chain reaction and
sequencing
PCR amplification of exon 15 of the
ATP2A2 gene was performed from ge-
nomic DNA. The optimal reaction mix-
ture (50 l) was: 0.4 M of each primer
(5'-TTT CCT CCT GCT TCC CAT TC-3'
and 5'-GCA ATC TGG AGA GCA AAC
TG-3'), 200 M dNTP mix, 200ng DNA
template, 0.1 U Taq polymerase (Perkin
Elmer), 1 X PCR reaction buffer (50 mM
KCl, 10 mM Tris HCl, pH 8.3, 1.5 mM
MgCl2). Amplification was carried out on
a 9600 GeneAmp Thermal Cycler and the
conditions were: initial denaturation, 4
min/95 °C; denaturation, 1 min/94 °C; an-
nealing, 2 min/58 °C; extension, 1.5 min/
72 °C; 35 cycles. All PCR products were
run on 2% agarose gels.
The amplicons were purified with
Concert Rapid PCR System (Gibco) to re-
move remaining amplification primers,
dNTPs and buffer. Cycle sequencing was
performed in a total volume of 20 l using
8 l ABI Prism Dye Terminator Cycle Se-
quencing Ready Reaction Kit with Am-
pliTaq FS Polymerase, 1 l sequencing
primer and 1–10 l amplified DNA. The
sequencing primers were the same as
those used for PCR amplification. A per-
kin Elmer 9600 thermal cycler was used
under the following conditions: 96 °C for
15 sec, 50 °C for 15 sec and 60 °C for 2
min for 25 cycles. The sequencing prod-
ucts were purified from residual termina-
tors with CentriSep Spin Columns (Per-
kin Elmer) and dried in vacuum centri-
fuge. DNA was resolved in 5 l loading
buffer consisted of 4 l deionized form-
amide and 1 l EDTA. Samples were de-
natured on 95 °C for 3 min, quick chilled
on ice and loaded on a denaturing poly-
acrylamide sequencing gel. Electrophore-
sis was run on an ABI 377 DNA Se-
quencer at 3 kV and 52 °C for 7 hours.
Analysis was performed using ABI Prism
Sequencing Analyser Software 2.1 and
sequences were aligned and analyzed
with Sequence Navigator Software.
Results
The proband in the investigated fam-
ily was a 28 year-old male with histolo-
gically confirmed dyskeratosis follicula-
ris. Skin lesions in the form of keratotic
papules first appeared when he was 13
years old. He was treated with retinoids,
topical keratolytic creams, ointments,
and isotretinoin gel as an out patient at
the Department of Dermatovenereology,
Zagreb University Hospital Center dur-
ing two years time period. The patient
had personality problems, which resulted
in antisocial behaviour.
At his second visit he had Staphylo-
coccal sepsis with fever (41 °C), numer-
ous keratotic papules and erosions of the
skin involving the entire trunk and legs.
The exacerbation of the disease started
five days after an extreme sun exposure
that resulted in sunburns. Besides high
fever, the patient had numerous follicular
keratotic red-brown papules on the clas-
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sical sites (scalp, retroauricular regions,
ears, sternal upper trunk, axillar and in-
guinal regions). Some lesions were con-
fluent, with erosions and intertriginous
madidations. He showed blisters on
hands and feet including digits. The toe-
nails were hyperkeratotic and yellowish
(Figure 2).
Staphylococcus aureus was isolated in
haemoculture and skin smears. Sepsis
was confirmed with the standard labora-
tory tests. Based on all findings the dis-
ease was classified as acral hemorrhagic
type, a rare variant of dyskeratosis folli-
cularis14.
The recovery, with epithelisation of all
erosions on the trunk, extremities and his
neck and head, followed after 14 days of
the treatment which included antibiotics
parenterally (cloxacillin 4  3 g i.v. and
amynoglicosides 2  120 mg i.v. in infu-
sions)15, and systemically with retinoid
(acitretin, 40 mg daily administered oral-
ly) and topically with antiseptics and ke-
ratolytics to promote epithelisation.
There were no symptoms of Darier's
disease in the proband's family. The pa-
tient's sister suffered from cystic acnei-
form lesions for which she had been
treated. In the mother's anamnesis heart
problems were indicated but not speci-
fied. On the basis of family medical re-
cord we could not decide whether our case
was sporadic or an inherited one.
Sequencing analysis of the exon 15 of
the ATP2A2 gene did not reveal any mu-
tation in the proband's genomic DNA,
and none in the DNA from family mem-
bers. Sequencing of the DNA from pro-
band's skin also failed to identify any mu-
tations. The sequence was also identical
with 10 unrelated healthy Croatian con-
trol individuals indicating that there
were no neutral polymorphisms among
individuals investigated. Although muta-
tions in exon 15 are reported to be the
most consistent mutations associated
with the acral hemorrhagic type of Da-
rier's disease, these mutations were not
recorded in the family we investigated.
Our results show that mutations in exon
15 of the ATP2A2 gene are not a neces-
sary prerequisite for acral hemorrhagic
type of Darier's disease.
The sequence data are shown in Fig-
ure 3.
Discussion
Genetic and molecular methods have
identified the gene responsible for Da-
rier's disease. Surprisingly, the culprit
did not lye in keratin or desmosomal ge-
nes or other genes for molecules that me-
diate adhesion between keratinocytes,
but rather in a gene that encodes a Ca2+
dependent pump, ATP2A2 gene5,12. Mu-
tations in ATP2A2 gene disrupt impor-
tant domains of the molecule and are
likely to result in complete or partial loss
of function of the SERCA 2 mutated
pumps. These findings support the propo-
sition that haploinsufficiency (i.e. a nor-
mal phenotype requires more gene prod-
uct than produced by a single copy of the
gene), is a common mechanism for the
dominant inheritance of DD. Haploin-
sufficiency results in impaired uptake of
cytosolic calcium into the endoplasmic re-
ticulum and consequent disruption of cal-
cium signaling. In the epidermis the pre-
sumed result is loss of cellular adhesion,
proliferation, impaired differentiation
and disordered keratinization. All those
calcium dependent processes are still in-
adequately explained at the cellular level
and also in keratoses development and
outcome. Pathological effects are produ-
ced under conditions of stress (UV expo-
sure, as was the case with our patient),
when calcium homeostasis is impaired.
Compensatory molecular mechanisms
contributing to extreme variability of the
disease progression may exist in man.
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It is known that some patients with
dyskeratosis follicularis develop basal
cell and squamous cell carcinomas16 and
it is well known that sunlight can act as
tumor initiator and tumor promoter17
and that UV exposure excerbates symp-
toms of Darier's disease. All the data pre-
sented support the link between sun, dis-
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Fig. 3. Sequence of exon 15 ATP2A2 (SERCA2) gene retrieved from the Genome Database
(http:// www.gdb.org/). Sequencing data of proband's: A. skin biopsy.
ordered keratynocytes and skin cancer. It
would be interesting to analyze Darier's
disease in light of other molecular mecha-
nisms of gene regulation, primarily pro-
motor methylation and involvement of
other modyfying genes in clinical outco-
me of Darier's disease.
The cutaneous manifestations in DD
vary considerably in severity even within
families. In cases where unusual cutane-
ous manifestations are present, usually
missense mutations were found. Never-
theless in two pedigrees investigated by
Ruiz-Perez et al.7, no consistency of the
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Fig. 3. Sequence of exon 15 ATP2A2 (SERCA2) gene retrieved from the Genome Database (http://
www.gdb.org/). Sequencing data of proband's: B. blood sample. Sequencing of the complementary
strand confirms lack of mutation. The rest of the family's DNA sequences were identical with the
ones shown.
phenotype could be established. All the
members affected had their own clinical
features.
No clustering or hot spots of muta-
tions in ATP2A2 gene have been obser-
ved4. It is also very interesting that the
majority of reported mutations are family
specific. Sakuntabhai et al.4 have found
no mutation in two families with typical
DD after direct sequencing of all the
exons of ATP2A2 which is consistent with
our report.
Lack of mutations observed in exon 15
of the ATP2A2 gene may obviously sug-
gest that the subtle mutations could be
confined to another region of the gene,
but also that larger deletions removing
whole exons could be involved. Another
explanation is the decrease in ATP2A2
protein expression via another molecular
mechanism. We are aware that sequenc-
ing the whole coding region of the ATP2A2
gene is necessary for definitive answers
and we leave it for future studies.
All these finding support the variabil-
ity of clinical manifestations of Darier's
disease and lack of genotype/phenotype
consistency to which our finding also con-
tributes.
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KLINI^KI SLU^AJ DYSKERATOSIS FOLLICULARIS (DARIEROVE
BOLESTI) HEMORAGI^NOG TIPA NIJE UZROKOVAN MUTACIJOM
EKSONA 15 GENA ATP2A2
S A @ E T A K
Dyskeratosis follicularis (Darierova bolest, DD) geneti~ka je bolest karakterizirana
patolo{kim promjenama keratinizacije, ~ija je posljedica razli~it klini~ki fenotip. Ne-
davno je otkriveno da dyskeratosis follicularis uzrokuju mutacije gena ATP2A2 na
12q24.1. Ovaj gen kodira proteinsku pumpu u sarko-endoplazmatskom retikulumu
stanice, kalcijevu ATPazu tipa 2 (SERCA 2). Mutacije eksona 15 vezane su uz hemora-
gi~ni tip Darierove bolesti. U na{em radu istra`en je ekson 15 ATP2A2 gena u obitelji
iz Hrvatske ~iji ~lan ima hemoragi~ni oblik DD. DNA izolirana iz biopsija ko`e, kao ni
konstitutivna DNA iz krvi bolesnika nisu pokazale mutacije eksona 15/ATP2A2. Se-
kvenciranjem eksona 15 ~lanova obitelji tako|er nije na|ena niti jedna mutacija. Ovi
rezultati upu}uju da mutacije eksona 15 nisu isklju~ivi uzrok hemoragi~nog oblika DD,
te doprinose razumijevanju klini~kih manifestacija ove bolesti.
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